# Three New Methods for Diagnosing Pancreas Cancer

> **NCT00259532** · NA · UNKNOWN · sponsor: **University of Copenhagen** · enrollment: 80 (estimated)

## Conditions studied

- Pancreas Cancer

## Interventions

- **PROCEDURE:** Ultrasound and contrast agent

## Key facts

- **NCT ID:** NCT00259532
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2009-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2009-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259532, "Three New Methods for Diagnosing Pancreas Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00259532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*